Patient Protection and Affordable Care Act (PPACA); Oregon Emerging Infections Pr

患者保护和平价医疗法案 (PPACA)；

• 批准号: 8135939
• 负责人: Paul R Cieslak
• 金额: $ 30.97万
• 依托单位: PUBLIC HEALTH SERVICES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-30 至 2012-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8135939
• 关键词: Patient; Protection; Affordable; Care; Act

DESCRIPTION (provided by applicant): The purpose of CDC's 10-state Emerging Infections Program (EIP) is to conduct surveillance and epidemiologic studies that go beyond the routine functions of most health departments, to answer questions of national public-health importance, and to train future epidemiologists. The purpose of this Affordable Care Act funding is to support and extend the capabilities of existing EIP sites, as well as to initiate new projects related to influenza and healthcare-acquired infections (HAIs). PPACA funding will be used by the Oregon Public Health Division to enhance support for the basic infrastructure of the EIP network, currently in place in Oregon. These funds will serve to support personnel currently working on EIP-related projects, offer training and education to various stakeholders, expand on the information technology and exchange efforts within our state and nationally, and to conduct the new projects. Specifically, funds will be spent on 4 focus areas: 1) Hire an additional 3.0 FTE to support multiple EIP activities. 2) Obtain education and training in relevant surveillance and epidemiologic areas - viz., infection control and health information. Up to eight EIP personnel will receive additional education and training in infection control, and up to 15 EIP personnel will receive advanced education and training in health information practices. 3) Support information technology to allow the capture of data regarding bloodstream infections from hemodialysis centers in the Portland metropolitan area. 4) Hire 1.75 FTE to enhance the general epidemiology and laboratory capacity related to HAIs and influenza. Oregon's EIP will work to establish a standard for evaluation and validation of surveillance for bloodstream infections. Additionally, the use of PCR for typing/subtyping of isolates from hospitalized patients with influenza within the Portland metropolitan EIP catchment area will both enhance the epidemiology and laboratory capacity of influenza in Oregon. Furthermore, the EIP influenza program will carry out a study to refine influenza burden projections in the state of Oregon. New stakeholders involved will be the hemodialysis centers that will be requested to submit positive blood stream infections notifications to ACDP. All other efforts undertaken by this funding opportunity will go toward sustaining and enhancing practices currently in place with longstanding EIP stakeholders (i.e. the Oregon State Public Health Laboratory) Proposed new staffing will include 1.0 FTE supervisory Research Analyst-4; 2.5 FTE Research Analyst 2; 1.0 FTE Administrative Specialist-2; and 0.25 FTE Microbiologist-2. The PPACA EIP funding furthers the OHA mission of keeping Oregonians healthy and safe through enhancement of communicable disease surveillance systems that promote early identification of outbreaks and improve the quality of data needed for priority setting, policy development, and prevention and control of infectious diseases. Most of the projects with the EIP do not constitute human subjects research. For any projects that involve research in human subjects, Oregon's EIP program will submit protocols to the Oregon Public Health Division Institutional Review Board. Summary data (i.e., without patient identifiers) will be shared with CDC and through local and national publications of public health merit. PUBLIC HEALTH RELEVANCE: The purpose of this Affordable Care Act funding through the Emerging Infections Program (EIP) is to support state and local health departments' surveillance infrastructure through enhancement of the epidemiology and laboratory capacity of the existing EIP network. PPACA funding will be used by the Oregon Public Health Division to enhance support for the basic infrastructure of the EIP network, currently in place in Oregon. These funds will serve to support personnel currently working on EIP-related projects, offer training and education to various stakeholders, expand on the information technology and exchange efforts within our state and nationally, as well as enhance surveillance for influenza & hospital-associated infections within our state.

疾病预防控制中心的10个州新发感染项目（EIP）的目的是进行超出大多数卫生部门常规职能的监测和流行病学研究，回答国家公共卫生重要性问题，并培养未来的流行病学家。《平价医疗法案》资助的目的是支持和扩展现有EIP站点的能力，以及启动与流感和医疗获得性感染（HAI）相关的新项目。PPACA资金将由俄勒冈州公共卫生司用于加强对EIP网络基本基础设施的支持，该网络目前位于俄勒冈州。这些资金将用于支持目前从事EIP相关项目的人员，为各种利益相关者提供培训和教育，扩大信息技术和我们州内和全国范围内的交流努力，并开展新项目。具体而言，资金将用于4个重点领域：1）额外雇用3.0名全职员工，以支持多项EIP活动。 2)获得有关监测和流行病学领域的教育和培训-即，感染控制和健康信息。多达8名EIP人员将接受感染控制方面的额外教育和培训，多达15名EIP人员将接受卫生信息实践方面的高级教育和培训。 3)支持信息技术，以便从波特兰大都市地区的血液透析中心获取有关血流感染的数据。 4)聘用1.75名全职员工，以加强一般流行病学及与甲型H1N1流感及流感有关的化验能力。俄勒冈州的EIP将致力于建立一个血流感染监测评估和验证的标准。此外，使用PCR对波特兰大都市EIP集水区内住院流感患者的分离株进行分型/亚型分析，将提高俄勒冈州流感的流行病学和实验室能力。此外，EIP流感计划将开展一项研究，以完善俄勒冈州的流感负担预测。涉及的新利益相关者将是血液透析中心，将被要求向ACDP提交阳性血流感染通知。所有其他的努力进行了这个资助的机会将走向维持和加强目前的做法与长期的EIP利益相关者（即俄勒冈州公共卫生实验室）拟议的新的人员配置将包括1.0全职监督研究分析师-4; 2.5全职研究分析师2; 1.0全职行政专家-2;和0.25全职微生物学家-2。PPACA EIP资助进一步促进了OHA的使命，即通过加强传染病监测系统来保持俄勒冈人的健康和安全，促进早期发现疫情，并提高优先事项设定，政策制定以及预防和控制传染病所需的数据质量。大多数EIP项目不构成人类受试者研究。对于任何涉及人类受试者研究的项目，俄勒冈州的EIP项目将向俄勒冈州公共卫生部机构审查委员会提交方案。汇总数据（即，没有病人标识符）将与疾病预防控制中心和通过公共卫生价值的地方和国家出版物共享。 公共卫生相关性：《平价医疗法案》通过新发感染方案（EIP）提供资金的目的是通过加强现有EIP网络的流行病学和实验室能力，支持州和地方卫生部门的监测基础设施。PPACA资金将由俄勒冈州公共卫生司用于加强对EIP网络基本基础设施的支持，该网络目前位于俄勒冈州。这些资金将用于支持目前从事EIP相关项目的人员，为各种利益相关者提供培训和教育，扩大信息技术和我们州内和全国范围内的交流努力，以及加强对我们州内流感和医院相关感染的监测。